Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Change in Receivables (2021 - 2025)

Historic Change in Receivables for Pulse Biosciences (PLSE) over the last 5 years, with Q3 2025 value amounting to $1000.0.

  • Pulse Biosciences' Change in Receivables rose 12500.0% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$26000.0, marking a year-over-year decrease of 120000.0%. This contributed to the annual value of -$48000.0 for FY2024, which is 5596.33% up from last year.
  • According to the latest figures from Q3 2025, Pulse Biosciences' Change in Receivables is $1000.0, which was up 12500.0% from $7000.0 recorded in Q2 2025.
  • Pulse Biosciences' 5-year Change in Receivables high stood at $95000.0 for Q3 2021, and its period low was -$107000.0 during Q2 2023.
  • Over the past 5 years, Pulse Biosciences' median Change in Receivables value was -$4000.0 (recorded in 2024), while the average stood at -$7473.7.
  • Over the last 5 years, Pulse Biosciences' Change in Receivables had its largest YoY gain of 60000.0% in 2024, and its largest YoY loss of 92000.0% in 2024.
  • Over the past 5 years, Pulse Biosciences' Change in Receivables (Quarter) stood at -$11000.0 in 2021, then surged by 54.55% to -$5000.0 in 2022, then soared by 200.0% to $5000.0 in 2023, then plummeted by 920.0% to -$41000.0 in 2024, then surged by 102.44% to $1000.0 in 2025.
  • Its last three reported values are $1000.0 in Q3 2025, $7000.0 for Q2 2025, and $7000.0 during Q1 2025.